v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
August 2024 Public Offering [Member]
June 2025 Public Offering [Member]
Common Stock
Common Stock
August 2024 Public Offering [Member]
Common Stock
June 2025 Public Offering [Member]
Additional Paid In Capital
Additional Paid In Capital
August 2024 Public Offering [Member]
Additional Paid In Capital
June 2025 Public Offering [Member]
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2023 $ 394,971     $ 6     $ 926,269     $ (530,752) $ (552)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023       55,585,305              
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs, Shares       1,519,453              
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs 48,740           48,740        
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs (301,373) $ 246,506     $ (1)   (301,373) $ 246,505      
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs, Shares       3,884,158 2,830,533            
Exercise of stock options 9,616           9,616        
Exercise of stock options, Shares       695,821              
Vesting restricted stock, Shares       168,731              
Issuance of shares under employee stock purchase plan, Shares       64,225              
Issuance of shares under employee stock purchase plan 1,134           1,134        
Stock-based compensation expense 41,213           41,213        
Unrealized gain on marketable securities 2,483                   2,483
Net loss (153,106)                 (153,106)  
Ending Balance at Sep. 30, 2024 892,930     $ 7     1,574,850     (683,858) 1,931
Shares, Outstanding, Ending Balance at Sep. 30, 2024       64,748,226              
Beginning Balance at Jun. 30, 2024 684,924     $ 6     1,308,388     (621,371) (2,099)
Shares, Outstanding, Beginning Balance at Jun. 30, 2024       61,572,383              
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs   $ (246,506)     $ (1)     $ (246,505)      
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs, Shares         2,830,533            
Exercise of stock options 5,053           5,053        
Exercise of stock options, Shares       340,482              
Vesting restricted stock, Shares       4,828              
Stock-based compensation expense 14,904           14,904        
Unrealized gain on marketable securities 4,030                   4,030
Net loss (62,487)                 (62,487)  
Ending Balance at Sep. 30, 2024 892,930     $ 7     1,574,850     (683,858) 1,931
Shares, Outstanding, Ending Balance at Sep. 30, 2024       64,748,226              
Beginning Balance at Dec. 31, 2024 835,619     $ 7     1,591,707     (754,610) (1,485)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024       64,890,193              
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs 0   $ (272,671)           $ (272,671)    
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs, Shares           5,899,500          
Exercise of stock options 12,789           12,789        
Exercise of stock options, Shares       629,222              
Vesting restricted stock, Shares       278,130              
Issuance of shares under employee stock purchase plan, Shares       44,129              
Issuance of shares under employee stock purchase plan 1,112           1,112        
Stock-based compensation expense 45,451           45,451        
Unrealized gain on marketable securities 2,986                   2,986
Net loss (224,370)                 (224,370)  
Ending Balance at Sep. 30, 2025 946,258     $ 7     1,923,730     (978,980) 1,501
Shares, Outstanding, Ending Balance at Sep. 30, 2025       71,741,174              
Beginning Balance at Jun. 30, 2025 971,480     $ 7     1,867,999     (896,805) 279
Shares, Outstanding, Beginning Balance at Jun. 30, 2025       70,557,442              
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs, Shares           855,000          
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs     $ 35,376           $ 35,376    
Exercise of stock options 4,553           4,553        
Exercise of stock options, Shares       275,484              
Vesting restricted stock, Shares       53,248              
Issuance of shares under employee stock purchase plan, Shares       0              
Issuance of shares under employee stock purchase plan 0           0        
Stock-based compensation expense 15,802           15,802        
Unrealized gain on marketable securities 1,222                   1,222
Net loss (82,175)                 (82,175)  
Ending Balance at Sep. 30, 2025 $ 946,258     $ 7     $ 1,923,730     $ (978,980) $ 1,501
Shares, Outstanding, Ending Balance at Sep. 30, 2025       71,741,174